Mereo BioPharma Group plc - American Depositary Shares (MREO) earnings
MREO earnings moved a median of +0.80% by the close. Quarterly and annual MREO reports and results, each read against the price at its own news timestamp. Back to the MREO overview →
19 measured MREO earnings events.
Where these MREO earnings landedvs 17 measured MREO earnings reactions
| Middle 50% of MREO earnings reactions | -1.44% to +3.81% |
|---|---|
| Median reaction (to close) | +0.80% |
| Measured reactions | 17 |
Point-in-time · zero look-ahead
Half of the 17 MREO earnings events with a measured close landed between -1.44% and +3.81%; 65% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Mereo BioPharma Group For: Jun 30 | SEC filing · Form 10-Q | -9.04% | -16.32% | |
| Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights | Press release | -9.04% | -16.32% | |
| Form 10-Q Mereo BioPharma Group For: Mar 31 | SEC filing · Form 10-Q | +2.16% | +0.41% | |
| Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates | Press release | +2.16% | +0.41% | |
| Form 10-K Mereo BioPharma Group For: Dec 31 | SEC filing · Form 10-K | -7.14% | +3.06% | |
| Form 10-Q Mereo BioPharma Group For: Sep 30 | SEC filing · Form 10-Q | +1.12% | +4.47% | |
| Mereo BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate Highlights | Press release | +1.12% | +4.47% | |
| Form 10-Q Mereo BioPharma Group For: Jun 30 | SEC filing · Form 10-Q | -0.30% | — | |
| Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights | Press release | -0.30% | — | |
| Form 10-Q Mereo BioPharma Group For: Mar 31 | SEC filing · Form 10-Q | +0.40% | -7.20% | |
| Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights | Press release | +0.40% | -7.20% | |
| Form 10-K Mereo BioPharma Group For: Dec 31 | SEC filing · Form 10-K | -0.43% | +0.85% | |
| Form 10-Q Mereo BioPharma Group For: Sep 30 | SEC filing · Form 10-Q | +1.32% | -1.44% | |
| Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update | Press release | -0.24% | -1.44% | |
| Form 10-Q Mereo BioPharma Group For: Jun 30 | SEC filing · Form 10-Q | -0.27% | +0.80% | |
| Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update | Press release | -0.27% | +0.80% | |
| Form 10-Q Mereo BioPharma Group For: Mar 31 | SEC filing · Form 10-Q | +2.54% | +3.81% | |
| Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update | Press release | +2.54% | +3.81% | |
| Form 10-K Mereo BioPharma Group For: Dec 31 | SEC filing · Form 10-K | +5.48% | +6.45% |
Keep exploring
More MREO: analyst actions → · SEC filings → · MREO overview →